Senores Pharma gets Philippine FDA approval for basket of 10 products
Ahmedabad: Senores Pharmaceuticals has announced that it has received marketing authorizations from the Philippine Food and Drug Administration (FDA) for a basket of 10 products across Therapies like Cardiovascular, CNS, and Pain management, etc.
This marks a significant step in the company’s strategy to expand its footprint in Southeast Asia and enhance access to affordable healthcare. The approvals provide Senores Pharmaceuticals with a strong platform to serve the Philippines.
The market size of these particular drugs in the Philippines is valued at US $23 million, underscoring the immense opportunity for growth and patient impact.
“These approvals reaffirm our commitment to delivering high-quality, affordable treatments for patients,” said Swapnil Shah, Managing Director of Senores Pharmaceuticals. “Philippines is a critical market in our regional expansion strategy, and this achievement strengthens our position as a trusted partner in advancing healthcare.”
With these regulatory endorsements, Senores Pharmaceuticals is poised to accelerate its presence in the Asia-Pacific region.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.